John Wiley & Sons, Inc., today announced that it will provide editorial
production, global marketing and distribution services for The
EMBO Journal, EMBO
reports and Molecular
Systems Biology. This expanded partnership with EMBO adds three
leading scientific journals alongside EMBO
Molecular Medicine, which Wiley has published since 2009.
The EMBO Journal is EMBO’s flagship title. Since its launch in
1982, the journal has maintained its position as one of the most
influential for the publication of important research advances and
authoritative reviews in molecular and cell biology.
EMBO reports publishes short-format papers in all research areas
of molecular biology while offering broadly accessible scientific review
and commentary, as well as a unique ‘Science and Society’ section that
explores how science is shaping the world.
Molecular Systems Biology is the premier journal dedicated to the
interdisciplinary fields of systems biology and synthetic biology. This
fully open access title publishes research that focuses on the analysis,
integration and modelling of molecular and cellular processes.
These titles will join EMBO Molecular Medicine, an open
access journal dedicated to research at the interface of clinical
research and the molecular life sciences. The journal publishes
high-quality research advancing the understanding, prevention and
treatment of human disease.
Together The EMBO Journal, EMBO reports, Molecular
Systems Biology and EMBO Molecular Medicine span
the whole spectrum of molecular biology, from structural biology and
biophysics to medical research, from molecules to systems, and from
viruses to humans.
All four titles will be available on the new EMBO
Press platform hosted by HighWire Press of Stanford University and
by Wiley
Online Library. HighWire Press will connect the EMBO titles to some
of the most prestigious journals in the life sciences. Wiley Online
Library is the world's broadest multidisciplinary collection of online
resources, hosting over 4 million articles and 1,500 journals covering
life, health, physical and social sciences.
All articles published by EMBO Molecular Medicine and Molecular
Systems Biology, as well as EMBO Journal and EMBO
reports articles where authors choose to publish open access, will
be freely available to read, download and share. All articles are
published in compliance with the requirements of the major funding
organizations and open access articles are published under the terms of
a Creative Commons Attribution License.
“We’re delighted to be building on the success of EMBO Molecular
Medicine and to be working with EMBO on its entire journal
portfolio,” said David Nicholson, Life Science Publishing Director,
Wiley. “EMBO is known to stand for excellence in the life sciences and
through this partnership Wiley will support the organization in
promoting and disseminating world class research to a global audience.”
“We welcome Wiley and HighWire Press as partners to support the launch
of EMBO Press,” said Bernd Pulverer, Head of Scientific Publications at
EMBO. “EMBO Press will provide the independence and flexibility to serve
optimally the scientific community and ensure that the EMBO scientific
journals remain at the forefront of technological advancement and
publication policy development in the years ahead.”
About EMBO:
EMBO is an organization of more than 1500 leading researchers that
promotes excellence in the life sciences. The major goals of the
organization are to support talented researchers at all stages of their
careers, stimulate the exchange of scientific information, and help
build a European research environment where scientists can achieve their
best work.
EMBO helps young scientists to advance their research, promote their
international reputations and ensure their mobility. Courses, workshops,
conferences and scientific journals disseminate the latest research and
offer training in techniques to maintain high standards of excellence in
research practice. EMBO helps to shape science and research policy by
seeking input and feedback from our community and by following closely
the trends in science in Europe.
For more information: http://www.embo.org/
About Wiley:
Wiley is a global provider of content-enabled solutions that improve
outcomes in research, education, and professional practice. Our core
businesses produce scientific, technical, medical, and scholarly
journals, reference works, books, database services, and advertising;
professional books, subscription products, certification and training
services and online applications; and education content and services
including integrated online teaching and learning resources for
undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a
valued source of information and understanding for more than 200 years,
helping people around the world meet their needs and fulfill their
aspirations. Wiley and its acquired companies have published the works
of more than 450 Nobel laureates in all categories: Literature,
Economics, Physiology or Medicine, Physics, Chemistry, and Peace.
Wiley's global headquarters are located in Hoboken, New Jersey, with
operations in the U.S., Europe, Asia, Canada, and Australia. The
Company's website can be accessed at http://www.wiley.com.
